FDA Regulations Allow Medical Devices Clinical Trials To Differ From Pharmaceutical Trials
Palm Beach, FL – March 8, 2019 – Clinical trials are the pathway for new drugs or devices to enter the U.S. and other worldwide markets. However, not all clinical trials are the same… A recent article by a 20+ year insider in the clinical trial industry said: “While clinical trials for medical devices have […]
Soliton’s RAP Device Received Institutional Review Board Approval of Non-Significant Risk Designation
Houston, TX – March 7, 2019 – Soliton, Inc., (NASDAQ: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center (“MD Anderson”), discusses that their RAP device received institutional review board (“IRB”) approval as a […]
